Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$15.24
+0.1%
$15.35
$12.00
$17.98
$94.39M0.9616,356 shs11,386 shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$1.30
+5.3%
$0.97
$0.53
$1.90
$95.73M1.06414,917 shs214,732 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$1.00
+3.1%
$4.28
$0.90
$5.70
$18.67M1.011.22 million shs5.00 million shs
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
$0.83
-0.9%
$0.71
$0.56
$0.99
$24.76M1.1559,025 shs208,955 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
+0.13%+0.93%-6.04%+7.86%-10.83%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
+5.28%-6.83%+15.63%+137.70%+22.17%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
+3.09%-79.63%-80.28%-70.15%-81.13%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
-0.93%+4.00%+19.41%+27.43%-13.85%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
1.5427 of 5 stars
1.35.00.00.02.61.70.6
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
0.7068 of 5 stars
0.02.00.00.02.00.81.3
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
1.8641 of 5 stars
0.03.00.00.03.43.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.67
Moderate Buy$1.28-0.90% Downside
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
0.00
N/AN/AN/A
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RVP, FONR, HYPR, and NVNO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$0.68 ➝ $0.85
8/14/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1.50 ➝ $2.00
6/3/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.92$3.09 per share4.94$24.78 per share0.62
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$12.89M7.82N/AN/A$0.45 per share2.88
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/A$1.72 per shareN/A
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
$38.16M0.65$0.02 per share48.25$3.31 per share0.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.19N/A8.19%5.31%3.97%9/26/2025 (Estimated)
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$40.72M-$0.52N/AN/AN/A-364.54%-84.82%-69.39%11/11/2025 (Estimated)
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$21.82M-$1.20N/AN/AN/AN/A-57.35%-53.49%10/29/2025 (Estimated)
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
-$7.01M-$0.29N/AN/A-41.11%-17.15%-9.33%N/A

Latest RVP, FONR, HYPR, and NVNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.12-$0.12N/A-$0.12$3.00 million$2.70 million
7/31/2025Q2 2025
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$0.28-$0.33-$0.05-$0.33N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/AN/A
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/A
5.02
4.41
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/A
11.81
11.81
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
0.01
8.57
5.92

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
34.71%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
7.58%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
30.98%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
16.00%
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
57.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
19077.83 million53.72 millionOptionable
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
3019.25 million16.17 millionOptionable
Retractable Technologies, Inc. stock logo
RVP
Retractable Technologies
24029.94 million13.47 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$15.23 +0.01 (+0.06%)
As of 08/22/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$1.30 +0.07 (+5.28%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$1.30 +0.01 (+0.39%)
As of 08/22/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

enVVeno Medical stock logo

enVVeno Medical NASDAQ:NVNO

$1.00 +0.03 (+3.09%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$0.99 -0.01 (-1.00%)
As of 08/22/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Retractable Technologies stock logo

Retractable Technologies NYSE:RVP

$0.83 0.00 (-0.57%)
As of 08/22/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.